Stefan H. I. Kappe
9Patents
2h-index
19Co-inventors
48Inventor score
Filing activity: Sep 12, 1997 → Feb 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6120770A | Plasmodium proteins useful for preparing vaccine compositions | Emerging Cross-Sectional Technologies | 29 | Expired |
| US7122179B2 | Live genetically attenuated malaria vaccine | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7722860B2 | Live genetically engineered protozoan vaccine | Emerging Cross-Sectional Technologies | 2 | Active |
| US8318183B2 | Plasmodium liver stage antigens | Emerging Cross-Sectional Technologies | 2 | Active |
| US7261884B2 | Live genetically attenuated malaria vaccine | Emerging Cross-Sectional Technologies | 1 | Active |
| US7718165B2 | Live genetically attenuated malaria vaccine | Emerging Cross-Sectional Technologies | 1 | Active |
| US11529404B2 | Doubly attenuated late liver stage malaria parasites and related compositions and methods | Emerging Cross-Sectional Technologies | 0 | Active |
| US8168166B2 | Live genetically attenuated malaria vaccine | Emerging Cross-Sectional Technologies | 0 | Active |
| US10905753B2 | Doubly attenuated late liver stage malaria parasites and related compositions and methods | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.